AAAAAA
Results: 51-67/67
Authors:
Coutts, M
Cui, K
Davis, KL
Keutzer, JC
Sytkowski, AJ
Citation: M. Coutts et al., Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation, BLOOD, 93(10), 1999, pp. 3369-3378
Authors:
Friedman, JI
Adler, DN
Davis, KL
Citation: Ji. Friedman et al., The role of norepinephrine in the pathophysiology of cognitive disorders: Potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease, BIOL PSYCHI, 46(9), 1999, pp. 1243-1252
Authors:
Friedman, JI
Harvey, PD
Kemether, E
Byne, W
Davis, KL
Citation: Ji. Friedman et al., Cognitive and functional changes with aging in schizophrenia, BIOL PSYCHI, 46(7), 1999, pp. 921-928
Authors:
Davis, KL
Braff, DL
Weinberger, DR
Citation: Kl. Davis et al., Protecting research subjects and psychiatric research: We can do both, BIOL PSYCHI, 46(6), 1999, pp. 727-728
Authors:
Charney, DS
Innis, RB
Nestler, EJ
Davis, KL
Nemeroff, CB
Weinberger, DR
Citation: Ds. Charney et al., Increasing public trust and confidence in psychiatric research, BIOL PSYCHI, 46(1), 1999, pp. 1-2
Authors:
Amin, F
Silverman, JM
Siever, LJ
Smith, CJ
Knott, PJ
Davis, KL
Citation: F. Amin et al., Genetic antecedents of dopamine dysfunction in schizophrenia, BIOL PSYCHI, 45(9), 1999, pp. 1143-1150
Authors:
Byne, W
Davis, KL
Citation: W. Byne et Kl. Davis, The role of prefrontal cortex in the dopaminergic dysregulation of schizophrenia, BIOL PSYCHI, 45(6), 1999, pp. 657-659
Authors:
Friedman, JI
Temporini, H
Davis, KL
Citation: Ji. Friedman et al., Pharmacologic strategies for augmenting cognitive performance in schizophrenia, BIOL PSYCHI, 45(1), 1999, pp. 1-16
Authors:
Harvey, PD
Silverman, JM
Mohs, RC
Parrella, M
White, L
Powchik, P
Davidson, M
Davis, KL
Citation: Pd. Harvey et al., Cognitive decline in late-life schizophrenia: A longitudinal study of geriatric chronically hospitalized patients, BIOL PSYCHI, 45(1), 1999, pp. 32-40
Authors:
Haroutunian, V
Purohit, DP
Perl, DP
Marin, D
Khan, K
Lantz, M
Davis, KL
Mohs, RC
Citation: V. Haroutunian et al., Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimerdisease, ARCH NEUROL, 56(6), 1999, pp. 713-718
Authors:
Davis, KL
Mohs, RC
Marin, DB
Purohit, DP
Perl, DP
Lantz, M
Austin, G
Haroutunian, V
Citation: Kl. Davis et al., Neuropeptide abnormalities in patients with early Alzheimer disease, ARCH G PSYC, 56(11), 1999, pp. 981-987
Authors:
Silverman, JM
Smith, CJ
Marin, DB
Birstein, S
Mare, M
Mohs, RC
Davis, KL
Citation: Jm. Silverman et al., Identifying families with likely genetic protective factors against Alzheimer disease, AM J HU GEN, 64(3), 1999, pp. 832-838
Authors:
Callaway, CA
Davis, KL
Kuehn, J
Butchko, LK
Pope, FL
Citation: Ca. Callaway et al., Civic center retrofit, ASHRAE J, 41(12), 1999, pp. 50-52
Authors:
Libon, DJ
Price, CC
Davis, KL
Ball, SF
Citation: Dj. Libon et al., Leukoaraiosis scale of Junque and neuropsychological measures, 1ST INTERNATIONAL CONGRESS ON VASCULAR DEMENTIA, 1999, pp. 87-90
Authors:
Davis, KL
Price, CC
Ball, SF
Libon, DJ
Citation: Kl. Davis et al., Error analysis of the CVLT-9, 1ST INTERNATIONAL CONGRESS ON VASCULAR DEMENTIA, 1999, pp. 135-139
Authors:
Price, CC
Davis, KL
Ball, SF
Lamar, M
Libon, DJ
Citation: Cc. Price et al., Towards an operational definition of bradyphrenia, 1ST INTERNATIONAL CONGRESS ON VASCULAR DEMENTIA, 1999, pp. 157-161
Authors:
Samuels, SC
Davis, KL
Citation: Sc. Samuels et Kl. Davis, Dementia and delirium, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, 1998, pp. 267-316